These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 10999819

  • 1. Linear growth and final height after treatment for Cushing's disease in childhood.
    Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO.
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3262-5. PubMed ID: 10999819
    [Abstract] [Full Text] [Related]

  • 2. Cushing's disease in childhood: presentation, investigation, treatment and long-term outcome.
    Savage MO, Lienhardt A, Lebrethon MC, Johnston LB, Huebner A, Grossman AB, Afshar F, Plowman PN, Besser GM.
    Horm Res; 2001 Sep; 55 Suppl 1():24-30. PubMed ID: 11408758
    [Abstract] [Full Text] [Related]

  • 3. Final adult height and body mass index after cure of paediatric Cushing's disease.
    Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, Plowman PN, Grossman AB, Savage MO.
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):466-72. PubMed ID: 15807878
    [Abstract] [Full Text] [Related]

  • 4. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
    Storr HL, Plowman PN, Carroll PV, François I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO.
    J Clin Endocrinol Metab; 2003 Jan; 88(1):34-7. PubMed ID: 12519825
    [Abstract] [Full Text] [Related]

  • 5. Growth in disorders of adrenal hyperfunction.
    Savage MO, Scommegna S, Carroll PV, Ho JT, Monson JP, Besser GM, Grossman AB.
    Horm Res; 2002 Jan; 58 Suppl 1():39-43. PubMed ID: 12373013
    [Abstract] [Full Text] [Related]

  • 6. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study.
    Saggese G, Federico G, Barsanti S, Fiore L.
    J Clin Endocrinol Metab; 2001 May; 86(5):1900-4. PubMed ID: 11344181
    [Abstract] [Full Text] [Related]

  • 7. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J.
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [Abstract] [Full Text] [Related]

  • 8. Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement.
    Gleeson HK, Stoeter R, Ogilvy-Stuart AL, Gattamaneni HR, Brennan BM, Shalet SM.
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3682-9. PubMed ID: 12915655
    [Abstract] [Full Text] [Related]

  • 9. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S, Pirazzoli P, Baronio F, Gennari M, Bal MO, Balsamo A, Gualandi S, Cicognani A.
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

  • 11. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM.
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion.
    Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, Savage MO.
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):169-74. PubMed ID: 14725677
    [Abstract] [Full Text] [Related]

  • 13. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings.
    Coutant R, Rouleau S, Despert F, Magontier N, Loisel D, Limal JM.
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520
    [Abstract] [Full Text] [Related]

  • 14. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J, Danner S, Simon D, Garel C, Czernichow P.
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [Abstract] [Full Text] [Related]

  • 15. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM, McKenna WJ, Brady AF, Sharland M, Elsawi M, Yamada M, Camacho-Hübner C, Kelnar CJ, Dunger DB, Patton MA, Savage MO.
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [Abstract] [Full Text] [Related]

  • 16. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F, Andrioli M, De Marinis L, Bianchi A, Giampietro A, De Martin M, Sacco E, Scacchi M, Pontecorvi A, Cavagnini F.
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [Abstract] [Full Text] [Related]

  • 17. Prevention of growth deceleration after withdrawal of growth hormone therapy in idiopathic short stature.
    Lampit M, Hochberg Z.
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3573-7. PubMed ID: 12161476
    [Abstract] [Full Text] [Related]

  • 18. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB, Lindberg A, Albertsson-Wikland K, Wilton P, Price DA, Reiter EO.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [Abstract] [Full Text] [Related]

  • 19. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
    Rappaport R, Mugnier E, Limoni C, Crosnier H, Czernichow P, Leger J, Limal JM, Rochiccioli P, Soskin S.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
    [Abstract] [Full Text] [Related]

  • 20. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.